Stay updated with breaking news from Mcelu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celularity Inc. (NASDAQ:CELU – Get Free Report) was the target of a large decline in short interest in the month of February. As of February 29th, there was short interest totalling 466,600 shares, a decline of 87.6% from the February 14th total of 3,750,000 shares. Based on an average daily volume of 264,800 shares, the […]
By Ben Glickman Intuitive Machines revealed that its moon lander spacecraft had come down on its side. Chief Executive Stephen Altemus said at a press...
By Stephen Nakrosis Biotechnology company Celularity on Friday said its board approved a 1-for-10 reverse split of the company's Class A common stock. "This...
By Will Feuer Celularity Chief Executive Robert Hariri said the biotechnology company expects to report 2023 revenue that is 23% to 27% higher than the...
By Ben Glickman Celularity on Thursday confirmed that it had entered a commercialization agreement with BioCellgraft to make biomaterial products for dental...